Cambridge, Massachusetts-based Ohana Biosciences, a biotechnology company with an emphasis on sperm-based fertility therapeutics and procedures, has announced that the start-up, funded by venture capital, has run out of funding and will be ceasing operations. The decision is said to affect all Ohana personnel, now estimated between 23 and 56 employees.
A statement by the company's CEO, Dr. Amber Salzman noted "It is an extremely disappointing day given the hard work and dedication of our team and the goals we set out to help the millions of people facing reproductive health challenges," Salzman wrote. "We are thankful to the patients, clinicians, our team, and many other people who have helped us on this journey."
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?